Trial now
US TSYS

2-Way Flow Observed

IDR

Rupiah Continues To Tread Water

EQUITIES

E-Minis Flat On The Day

AUSSIE BONDS

AOFM Weekly Issuance Slate

CNH

Redback Hugs Tight Range

GLOBAL MARKET/OPINION

Carl Quintanilla at CNBC tweets:

  • "Johnson & Johnson Plans 60,000-Person Pivotal Trial of Experimental Covid-19 Vaccine"
  • "J&J Sees Trial Starting by End of September"
  • "Covid-19 Vaccine Could Become Available in Early 2021, J&J Says"
MNI London Bureau | +44 203-865-0981 | tom.lake@marketnews.com